Dithiothreitol (Dm) activation of the adhesive function of several different integrins suggests the existence of a common DlT-sensitive integrin regulatory element. Uill/E3, a natural killer (NK) cell-resistant murine target cell line genetically engineered t o constitutively express human intercellular adhesion molecule-l (ICAM-1; CD%) was used in a flow cytometric experimental model t o evaluate D l T effects on the NK cell integrin adhesion molecule, leukocyte function antigen-l (LFA-1; aU2, CD1 la/CD18). D l T and several structurally related dithiol compounds elicited a dramatic elevation in conjugate formation that was dependent on target cell CAM-1 expression, was blocked by LFA-1 (YL or p2 chainspecific antibodies, and occurred in the absence of Ui11/E3 target cell exposure t o D l l or quantitative changes in NK cell membrane LFA-1 expression. This avidity modulation of LFA-1 by DlT required actin polymerization, was abrogated by the protein kinase C inhibitor calphostin C, involved activities of calyculin A-and okadaic acid-sensitive serine/threonine protein phosphatases PP-l and/or PP-PA but not geldanamycin-sensitive tyrosine kinases, and differed with respect t o kinetics and enzyme inhibitor sensitivity from LFA-1 activation promoted by cross-linking of NK cell CD16 or phorbol ester treatment. A key structural feature of D l T was the presence of two thiol groups, both reduced but not SH group spatial positioning, are important in LFA-activation for reasons other than cation chelation or disulfide reduction. Despite apparent differences in some aspects of D l T activation of different integrins, the actin-dependent cytoskeleton or membrane skeleton was implicated as a likely candidate for a common locus of DTT action.
By Bruce S. Edwards, Mark S. Curry, Eileen A. Southon, Anita S.-F. Chong, and Lloyd H. Graf Jr Dithiothreitol (Dm) activation of the adhesive function of several different integrins suggests the existence of a common DlT-sensitive integrin regulatory element. Uill/E3, a natural killer (NK) cell-resistant murine target cell line genetically engineered t o constitutively express human intercellular adhesion molecule-l (ICAM-1; CD%) was used in a flow cytometric experimental model t o evaluate D l T effects on the NK cell integrin adhesion molecule, leukocyte function antigen-l (LFA-1; aU2, CD1 la/CD18). D l T and several structurally related dithiol compounds elicited a dramatic elevation in conjugate formation that was dependent on target cell CAM-1 expression, was blocked by LFA-1 (YL or p2 chainspecific antibodies, and occurred in the absence of Ui11/E3 target cell exposure t o D l l or quantitative changes in NK cell membrane LFA-1 expression. This avidity modulation of LFA-1 by DlT required actin polymerization, was abrogated by the protein kinase C inhibitor calphostin C, involved activities of calyculin A-and okadaic acid-sensitive serine/threonine protein phosphatases PP-l and/or PP-PA but not geldanamycin-sensitive tyrosine kinases, and differed with respect t o kinetics and enzyme inhibitor sensitivity from LFA-1 activation promoted by cross-linking of NK cell CD16 or phorbol ester treatment. A key structural feature of D l T was the presence of two thiol groups, both reduced but not physically adjacent as in the nonstimulatory dithiol, 2,3-EUKOCYTE FUNCTION ANTIGEN-l (LFA-1) is a membrane-spanning heterodimeric glycoprotein that belongs to the 02 integrin family of adhesion receptors (aLP2) and is broadly distributed among leukocytes.'~* It consists of the 180-kD a L subunit (CD1 la) noncovalently associated with the 95-kD p2 subunit (CD18) and mediates both homotypic and heterotypic adhesion between leukocytes and a variety of other cell types that express one or more of the known LFA-1 counter-receptor molecules, which include intercellular adhesion molecule-l (ICAM-l), ICAM-2, and ICAM-3."5 Intracellular signals transmitted in conjunction with T-cell activation, via either T-cell receptor (TCR) cross-linking or exposure of T cells to phorbol esters, dimercaptopropanol. LFA-1 activation was not because of D l T chelation of Ca2' or Zn2+. lmmunoblotting studies identified multiple NK cell plasma membrane-associated proteins t o be reduced by DTT under LFA-l-activating conditions, but similar effects were also promoted by reducing agent treatments that failed t o alter adhesive function. Direct chemical modification of LFA-1 seemed an unlikely basis of activation because (1) D l T activated LFA-1 in HSBP T cells without detectable disulfide reduction in LFA-1 (YL or p 2 chains immunoprecipitated from these cells and (2) D l T treatment of NK cells did not hinder binding of KIM127 and KIM185, monoclonal antibodies that recognize epitopes in the potentially DlT-susceptible cysteine-rich domain of the p2 chain. Thus, these results extended the range of DlTactivatible integrins t o include NK cell LFA-1 and characterized for the first time signaling-associated enzymatic activities involved in DTT activation of NK cell LFA-1. Moreover, they suggested that structural features of DlT, particularly SH group spatial positioning, are important in LFA-activation for reasons other than cation chelation or disulfide reduction. Despite apparent differences in some aspects of D l T activation of different integrins, the actin-dependent cytoskeleton or membrane skeleton was implicated as a likely candidate for a common locus of DTT action.
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induce an increase in the strength of LFA-I adhesion to ICAM-l without changing levels of T-cell LFA-1 expression.h Thus, avidity regulation of LFA-l in T cells reflects an alteration in the conformation or membrane distribution of preexisting membrane-associated LFA-1 molecules. The LFA-l molecule is an important adjunct to natural killer (NK) cell cytolytic activity, and its function in this context is dependent on its expression by the NK cell rather than by the cell targeted for de~truction.~.~ LFA-I is constitutively expressed at significantly higher levels on NK cells and some CD8+ T cells as compared with that of other lymphocyte subpopulations existent in peripheral blood (PS)? a finding which suggests LFA-I to be of particular importance in the biological functions of these cells. Monoclonal antibodies (MoAbs) directed against LFA-I generally inhibit NK cell-mediated cytolysis by preventing NK-target cell adhesion,'o"3 but adhesion-independent inhibitory effects of MoAbs have also been rep~rted.'~ Variable states of LFA-I adhesive interaction with ICAM-1 have also been implicated in studies of the effects of activating stimuli on NK cell migration on ICAM-I-coated surfaces." Moreover, LFA-1 has been implicated as an important adhesive element enabling the migration of human NK cells into multicellular human glioblastoma spheroids.16 Thus LFA-l-dependent adhesion may be a central element in tumor infiltration as well as in tumor cytolysis.
Dithiothreitol (DTT) is a reducing agent that has been reported to modulate the adhesive status of several different integrins. In vitro exposure of neutrophils to DTT enhanced their adhesion to plastic and endothelium via the CD1 lb/ DlTHlOL ACTIVATION OF LFA-l 2289 CD18 (aMP2) integrin adhesion molecule." DTT also promoted HL-60 myeloid cell adhesion to fibronectin via the a501 integrin adhesion molecule.'8 Exposure of platelets to DIT induced platelet binding of soluble '=I-fibrinogen in conjunction with fibrinogen-dependent aggregation of platel e t~, '~ processes normally associated with affinity modulation of aIIbp3 integrin (platelet GPIIb-IIIa).m These results suggest that a common feature of integrins may be a susceptibility to avidity modulation by DTT. To test this hypothesis, the present study was undertaken to determine if adhesion mediated by the P2 integrin, LFA-1, of NK cells was also subject to modulation by DIT. An NK-resistant murine target cell genetically engineered to constitutively express the human ICA"1 adhesion molecule was used in a flow cytometric experimental model to perform these studies. This approach permitted evaluation of the LFA-IILCAM-l interaction at the single cell level and in the physiological context of the NK-target cell conjugate. DTT and structurally related dithiol compounds were determined to be potent activators of LFA-l-dependent adhesion in NK cells. The activation was strictly dependent on apparent signal transduction processes in which activities of protein kinase C (PKC) and serine/threonine protein phosphatases but not geldanamycinsensitive tyrosine kinases were implicated. Moreover, LFA-1 avidity modulation by DTT differed in distinctive ways from that promoted by phorbol ester treatment or crosslinking of NK cell CD16. Thus, these findings extended the range of DTT-activatible integrins to include LFA-1 and identified for the first time a series of signaling interactions that characterized the DTT activation pathway in NK cells.
MATERIALS AND METHODS
NK and target cells. Lymphocytes and NK cells were prepared from healthy human volunteers as previously described?' Briefly, PB lymphocytes (PBLs) were prepared from heparinized PB that was separated on Ficoll-Paque (Pharmacia, Piscataway, NJ) and depleted of monocytes by two rounds of absorption to plastic. NK cells were enriched by negative selection of CD5-CD20-PBLs using PBLs coated with MoAbs directed against CD5 and CD20 (T1 and B1; Coulter Immunology, Hialeah, FL) in combination with magnetic beads coated with antibodies directed against mouse IgG (BioMag; Perceptive Diagnostics, Cambridge, MA). NK cell preparations typically consisted of 89% to 95% CD56' NK cells and only 3% to 5% CD3+ T cells.z' NK cells were routinely suspended in serum-free HI3104 tissue culture medium (Irvine Scientific, Santa Ana, CA), cultured overnight at 37°C under 5% COz, and used for experimentation the following day.
The Uill cell line was derived by primary transfection of the murine B78H1 melanoma cell line with genomic DNA from a human melanoma cell line (Col0 38) and subsequent selection for expression of a 96-kD antigen immunologically identified as ICA"1 ?2.23 Two subsequent rounds of transfection and selection were performed to remove extraneous human genomic DNA unrelated to ICA"1. We have verified expression of ICA"1 (CD54) and lack of expression of a series of other human antigens (LFA-3KD58, CDlla, CD18, CD2, CD45, CD3, CD5, and CD16) by immunofluorescence analysis. Uill clones differing in level of ICAM-1 expression were isolated by flow cytometric autocloning of Uill cells immunofluorescently stained with anti-ICAM-l MoAb (84H10; GenTrak, Plymouth Meeting, PA used to excite blue indo-l fluorescence emission (detected at S10 t 10 nm), and the 488-nm line from an argon ion laser (400 mW) was used to excite orange SNARF-I fluorescence (detected at 570 2 S nm). The availability of two spectrally distinct NK cell dyes was helpful for avoiding analysis artifacts caused by drugs that fluoresced at one of the excitation wavelengths. When such drug fluorescence occurred, NK cells were loaded with the dye appropriate for analysis at the alternative excitation wavelength. Under appropriate loading conditions, neither dye affects the ability of NK cells to kill or form conjugates with NK-sensitive target cells."~*' In conjugate experiments with HSB2 T cells, the T cells were loaded with indo-l and the target cells with SNARF-l (cells were not sufficiently different in size for distinction on the basis of light scatter). Conjugates were identified as blue fluorescent HSB2 cells in association with red fluorescent target cells and fluorescence emission of both dyes was excited at UV wavelengths as previously described.2' HSB2 cells were combined with target cells at a 1.3 ratio, centrifuged at 400g for I minute, then immediately resuspended, and analyzed in the flow cytometer. A 37°C water bath coupled to an insulated circulating fluid temperature control system was used to maintain the sheath fluid buffer and cell sample at a physiological temperature throughout the course of each flow cytometric analysis.
A.ssays for plasma membrane-associated thiols. A previously reported experimental approach26 was adapted as a means to measure extracellular membrane thiols. Subsequent to various treatments, cells were incubated for 10 minutes at 37°C with 50 pmoVL 3-(Nmaleimido-propionyl) biocytin (MPB; Molecular Probes), a biotinconjugated maleimide derivative that is membrane-impermeant and reacts selectively with thiol SH groups.27 After removal of unreacted MPB by centrifugation washes, cells were stained for 30 minutes at 4°C with 20 pg/mL fluorescein-conjugated avidin (Becton Dickinson, Mountain View, CA) to detect biotinylated membrane SH groups and were analyzed by flow cytometry (excitation at 488 nm with emission detected at 425 _f 10 nm). MPB treatment had no detectable effect on membrane permeability as assayed by ethidiumbromide exclusion. Relative changes in membrane thiols were estimated on the basis of the median fluorescence intensity resulting from MPBhvidin staining, expressed in terms of molecules of equivalent soluble fluorescein (MESF), as quantitated by comparison with a standard curve generated with fluorescein microsphere standards (Flow Cytometry Standards, Research Triangle Park, NC).
To determine the molecular weight characteristics of membraneassociated protein thiols, cells were incubated with MPB as above, Beads were then suspended in Laemeli sample buffer without reducing agents (0.0625 mol/L Tris-HCI, pH 6.8/10% glycerol/2% SDS), incubated in boiling water for S minutes, and centrifuged at 12,000g for 2 minutes, and the supernatants were separated by SDS-PAGE on 8% gels for subsequent transfer to nitrocellulose and immunoblot analysis. Membrane proteins biotinylated with either MPB (thiolspecific) or Sulfo-NHS-biotin (general protein label) were detected by incubating membranes with HRP-conjugated streptavidin as described above. In preliminary control experiments, it was determined that the S-minute incubation in boiling water did not cause detectable changes in MPB-labeled proteins in whole cell lysates.
Antibody blocking, cross-linking, und staining ussays. For blocking studies, cells (S p L at S X IOhcells/mL) were added with S L blocking MoAb (200 pg/mL) and incubated for 30 minutes on ice. Cells were then added with 1. 50 pL of standard solution with or without adhesion modulating drugs, incubated for I O minutes at 37"C, and combined with target cells for conjugate analysis as described above. IgGl MoAbs directed against CD1 la (25.3) and CD18 (BL5) were obtained from lmmunotech (Westbrook. ME). Control IgGl MoAbs directed against CD56 (N901) were obtained from Coulter Cytometry (Hialeah, E).
For CD16 cross-linking assays, B73.1 MoAbs (Immunotech) were added to NK cells (100 pg/mL in 10 pL) for varying lengths of time, after which target cells were added and conjugate formation and analysis performed as described above.
CD1 la and CD18 expression was evaluated by direct immunofluorescence staining of NK cells in 96-well microplates and by flow cytometric immunofluorescence analysis as previously described.'x Fluorescein-conjugated derivatives of MoAbs used in blocking studies were obtained for this purpose (Immunotech). KIM127 and KIM185 MoAbs"." were a kind gift from Dr M. Robinson (Celltech, Berkshire, UK). Binding of these MoAbs was detected by indirect immunofluorescence staining with fluorescein-conjugated affinitypurified goat antibodies directed against mouse IgG (Kirkegard and Perry, Gaithersburg, MD). Both first and second antibody incubation steps (30 minutes each) were performed at 37°C for KIM 127 (the epitope is poorly expressed at 4°C) and at 4°C for KIM1 85. KM127 and KIM185 MoAbs were used at concentrations of 50 and 10 pg/ mL, respectively. Fluorescein fluorescence of 488 nm light scattergated NK cells was excited and detected by flow cytometry as described above. 
RESULTS

Activation of N K cell adhesion to ICAM-I-transfected target cells by dithiol-reducing agents.
A flow cytometric experimental model that we have used previously to investigate NK cell interactions with target cells at the single cell leve12'*24.25 was adapted for the study of LFA-1 regulation in NK cells. As a target cell, we used the U i l l E 3 cell line, a murine melanoma cell line that is resistant to lysis by human NK cells and that, via gene transfer, constitutively expresses human ICAM-1, a counter-receptor for LFA-l.' NK cells purified from resting PBLs were incubated with DTT, then centrifuged together with U i l l E 3 target cells to facilitate NK-target cell contact, resuspended, and submitted for flow cytometric analysis of conjugate formation.
Exposure of NK cells to 500 pmovL DTT resulted in a time-dependent elevation in the frequency of NK, adherent to U i l l E 3 target cells in which NK, increased from ~5 % in the absence of DTT to a peak of ~4 0 % .
This occurred within 10 minutes of DTT addition and was sustained for at least an additional 20 minutes thereafter (Fig l) . NK cell treatment with 50 pmoVL DTT failed to significantly stimulate conjugate formation over the entire 30-minute exposure time. The standard solution in which NK cells were normally suspended for treatments and conjugate assays was routinely supplemented with 1 mg/mL HSA, a protein rich in cystine residues3' with which D I T might have interacted. To determine if HSA influenced the adhesion-stimulatory effects of DTT, NK cells were exposed to DTT for 1 to 30 minutes in the absence of HSA, then combined with U i l l E 3 target cells in an HSA-supplemented solution for performance of conjugate assays. The kinetics and DTT dose-dependence of conjugate formation were similar when NK cells were exposed to DTT in either the presence or absence of HSA (Figs 1A and B, respectively), thus eliminating the likelihood that HSA-DTT interactions either inhibited or potentiated DTT effects under these experimental conditions. In additional experiments, it was determined that after a 10-minute exposure of NK cells to 500 pmol/L DTT, a comparable elevation and sustained level of NK, was attained even when DTT was removed by centrifugation washes before conjugate formation (see below in Table 1 and other data not shown). This result, together with the kinetics data (Fig l) , clearly indicated that the observed elevation of NK, reflected DTT effects on the NK cell and not on the U i l l E 3 target cell.
Under conditions in which DTT induced a substantial increase in NK cell adhesion to the U i l l E 3 target cells (from 8% to 60% NK,), NK cell adhesion to B78H1, the parental untransfected target cell line from which U i l l E 3 was derived, was negligible in either the presence or absence of DTT (Fig 2A) . When NK cells were exposed to isotype- cells by 90-95%, whereas a control MoAb directed against the NKHl/NCAM antigen of NK cells (CD56) had no significant inhibitory effect (Fig 2B) . These results indicated that the elevation in NK, promoted by DTT was fully attributable to an increase in adhesive interactions between NK cell LFA-1 and target cell ICAM-1.
To investigate the molecular requirements for LFA-1 activation by DTT, NK cells were exposed to a series of thiol compounds that differed with respect to structure and oxidation state (Fig 3) . Dithioerythritol, a stereoisomer of DTT, was consistently as effective as DTT. 1,4-butanedithiol, which differs from DTT with respect to the absence of hydroxyl groups at the 2 and 3 positions, also significantly stimulated LFA-1 -dependent adhesion. By contrast, exposure of NK cells to oxidized DTT (trans-4,5-dihydroxy-1,2-dithiane) failed to stimulate. Also nonstimulatory were the dithiol compound, DMP, and the monothiol compound, 2-mercaptoethanol (Fig 3) . The results shown in Fig 3 were representative of 3 to 20 separate experiments performed with each of the compounds. The nonstimulatory compounds also failed to elicit significant stimulation when each was tested over a concentration range of 5 pmol/L to 2 mmol/L (data not shown). These results supported the hypothesis that reduced SH groups were essential for LFA-1 activation by DTT (because oxidized DTT was ineffective) and that other constraints, such as the presence of two appropriately spaced SH groups in a single molecule (ie, not adjacent as in 2,3-dimercaptopropanol), were also of importance. Adhesion stimulation is not caused by chelation of divalent cations. Removal of Ca" ions in the presence of Mg2+ ions results in the upregulation of LFA-1 adhesive function, apparently by promoting conformational changes in LFA-1 molecules.32 Because DTT has been reported to chelate divalent experiments were performed to determine if ments indicated to be the maximum EGTA-inducible effect (ie, NK, could not be increased further in the presence of higher EGTA concentrations; data not shown). Exposure of NK cells to DTT alone resulted in a consistently greater increase in NK, frequency than that achieved by addition of EGTA alone (see Table 1 , experiments no. 1 and 2). The LFA-1 stimulatory effects of EGTA and DTT were also additive when NK cells were exposed to the two reagents in combination (see Table 1 , experiment no. 1). When NK cells were washed free of EGTA after a 10-minute exposure, the frequency of NK, was restored to the basal levels observed in untreated control NK cells (see Table 1 , experiment no. 2). Thus, the LFA-1 stimulatory effects of chelating Ca" with EGTA were rapidly reversed when extracellular Ca2+ was restored subsequent to EGTA removal. This was in distinct contrast to the effects of washing NK cells free For
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of DTT subsequent to a 10-minute exposure, under which circumstances the frequency of N& remained elevated (see Table 1 , experiment no. 2). These results indicated that the mechanism by which DTT stimulated LFA-l-dependent adhesion was unlikely to involve extracellular chelation of Ca2+. Chelation of Zn" by DTT was also an unlikely basis of LFA-1 activation, because 2,3-dimercaptopropanol, which binds Zn2+ more stably than D'IT, failed to stimulate LFA-1 adhesion (Fig 3) .
Role of protein phosphorylation and the actin-dependent cytoskeleton. Enzymatic activities of PKC and serinehhreonine protein phosphatases have been implicated in regulation of LFA-1 adhesive fun~tion.6,~~ Therefore, we investigated the possible role of these enzymatic activities in the elevation of LFA-l-dependent adhesion promoted by DTT. Adhesion-stimulatory effects of DTT were abrogated in the presence of the selective PKC inhibitor, calphostin C, at inhibitor concentrations of 0.2 pmol/L or more (Fig 4A) . Stimulation of conjugate formation by the PKC-activating drug, PMA, was inhibited by calphostin C with a concentration-dependence profile similar to that of DTT (Fig 4A) . Calyculin A, a potent and selective inhibitor of serinekhreonine protein phosphatases PP-l and PP-2A,35 also inhibited conjugate formation, but the pattern of inhibition differed from that of calphostin C with respect to two important features. First, unlike calphostin C, calyculin A not only completely blocked the adhesion-stimulatory effects of PMA, but also abrogated even the basal levels of conjugate formation routinely observed to occur with unstimulated NK cells (Fig 4B) . Second, although calyculin A significantly reduced the elevation in NK, promoted by DTT, only partial reduction was achieved at the 0.05-to 0.5-pmol/L concentrations that completely inhibited basal and PMA-stimulated conjugate formation. Similar results were obtained with okadaic acid, another selective inhibitor of serinekhreonine protein phosphatases that inhibits via a different mechanism.35 In pooled results of multiple experiments, calyculin A and okadaic acid each reduced NK, to -50% of the level promoted by DTT in control cultures, while otherwise eliminating NK, that occurred in either the presence or absence of PMA (Fig 4C) . The protein tyrosine kinase (PTK) inhibitor, geldanamycin, showed no significant inhibitory effects on DTT-activated LFA-l-dependent adhesion, which is comparable with its lack of effect on PMA-stimulated conjugate formation (Fig 4C) . This geldanamycin treatment protocol was sufficient to inhibit NK cell PTK activity as indicated by its ability to inhibit LFA-1 activation promoted via a known PTK-associated stimulus (see below). These results indicated that the activation of LFA-l-dependent adhesion by DTT involved a signal transduction pathway(s) characterized by (1) an essential requirement for PKC activity, ( 2 ) a lack of requirement for geldanamycin-sensitive PTK activity, and (3) at least a partial dependence on protein phosphatase activities of PP-l and/or PP2A.
A role of the actin-dependent cytoskeleton or membrane skeleton in LFA-l-dependent adhesion has been suggested by adhesion-inhibiting effects of drugs that interfere with actin polyrnerizati~n.~ Therefore, NK cells were treated with DTT in the presence of cytochalasin D, an inhibitor of actin polymerization, to determine if cytoskeleton-associated actin assembly was an important feature of its adhesion-stimulatory effects. In representative experiments with NK cells from two donors (Fig 5) , activation of LFA-l-dependent adhesion by DTT was consistently inhibited to a significant extent by cytochalasin D. In some experiments, cytochalasin D inhibited both D'IT-and PMA-stimulated adhesion to a comparable extent (eg, as with donor no. l), whereas, in others, the effect on DTT-stimulated adhesion was less pronounced but still significant (eg, as with donor no. 2).
Comparative analysis of a CDI6-triggered tyrosine kinase-linked LFA-1 activation pathway. The FcRIII receptor (CD16) of NK cells is a lytic pathway-activating membrane receptor that mediates antibody-dependent NK cell-mediated cytotoxicity, an NK-target cell interaction in which LFA-1 plays an important r~l e .~~,~' To determine if the CD16-triggered activation pathway was functionally linked to LFA-1, NK cells were incubated for varying lengths of time with cross-linking anti-CD16 MoAbs before the addition of U i l l E 3 target cells. A peak increase in conjugate formation occurred at =6 minutes postaddition of MoAbs followed by a decrease to lesser, but still elevated, levels of NK, in the ensuing 20 minutes (Fig 6A) . Conjugate formation was dependent on ICAM-1 expression by the target cells and was blocked by MoAbs directed against NK cell CD1 l a (Fig 6B) , thus verifying the dependence on LFAl/ICAM-1 adhesive interactions and confirming the existence of a functional linkage between CD16 and LFA-1. CD16-stimulated conjugate formation was significantly but only partially inhibited by 1 pmom calphostin C (Fig 6C) , a result resembling the reported partial sensitivity of T-cell receptor-stimulated LFA-l activation to the presence of a PKC inhibitor.6 Geldanamycin also significantly blocked CD16-promoted LFA-1 activation (Fig 6C) , suggesting that the reported sensitivity of NK cell antibody-dependent lytic activity to tyrosine kinase inhibitors3' might be attributable, at least in part, to effects on LFA-l-dependent aspects of NK-target cell adhesion. CDl6-dependent activation of LFA-1, similar to PMA-but not DTT-mediated activation, was abrogated in the presence of 0.5 pmol/L calyculin A ( Fig 5C) .
DTT reducing effects on membrane-associated proteins. Because DTT is a potent reducing agent, we sought to test the hypothesis that it might elicit an LFA-l-activating signal by virtue of its ability to reductively modify a signal-transducing NK cell membrane protein(s). To evaluate this possibility, we measured the relative abundance of free SH groups on NK cell membranes before and after DTT treatment, using the biotin-conjugated SH group-selective probe, MPB.26,27 NK cells treated with or without DTT were incubated with MPB and subsequently stained with fluoresceinconjugated avidin to detect membrane-bound MPB. In a representative experiment, there was a low but significant level of MPB bound to untreated NK cells that presumably reflected the basal level of free membrane SH groups expressed by resting NK cells (Fig 7A) . DTT treatment resulted in an increase in median MPB fluorescence intensity that corresponded to an estimated 10-fold increase in membrane SH groups (Fig 7B) . DMP, a dithiol-reducing agent that failed For personal use only. on September 14, 2017. by guest www.bloodjournal.org From to activate LFA-I (Fig 3) , promoted a comparable 12-fold increase in membrane SH groups, whereas 2-mercaptoethano1 promoted only a twofold increase (Figs 7C and D, treated NK cells were 22,000 2 13,000 and 19,000 2 10,000 MESF (mean 2 SD), respectively. These results suggested that the two dithiol reagents, DTT and DMP, were equally effective in generating free SH groups on NK cell membranes and argued against the likelihood that DTT activated LFA-l because it was simply more efficient than DMP in reducing membrane proteins. However, it remained a possibility that the disparate effects of DTT and DMP on LFA-1 might have reflected different patterns of protein reactivity. To characterize proteins affected by DTT treatment, intact NK cells were exposed sequentially to DTT and MPB as above, then lysed in 1% Triton X-100. Postnuclear detergentsoluble proteins were separated by SDS-PAGE, blotted onto nitrocellulose, and probed with HRP-conjugated avidin to detect MPB-bound proteins. Of the multiple bands of MPBbound proteins that were sometimes evident in untreated NK cells, three heavily labeled proteins were consistently detected that migrated at apparent molecular weights of 46, 60, and 69 kD (Figs 8a and b, lanes D and G, respectively) . In the presence of an LFA-l-activating concentration of DTT (500 pmoVL), the 69-kD protein showed a time-dependent increase in MPB reactivity, together with a progressive shift to an apparent molecular weight of e 7 6 kD that occurred within 10 minutes (Fig 8a, lanes A-C) . This protein was also heavily labeled in the presence of a nonactivating concentration of DTT (50 pmol/L) after either a 10-minute (Fig 8b, lane B) or a 30-minute (Fig 8a, lane E) incubation at 37"C, but at neither time point did there occur a significant shift in molecular weight. By contrast, DMP treatment resulted in MPB labeling and a molecular weight shift in the 69-kD protein that was comparable with that promoted by 500 pmol/L DTT (Fig 8b, lane F) . Additional prominent MPB-reactive protein bands were variably induced in the presence of 500 pmoVL DTT (eg, at x 3 0 and 147 kD). However, labeling of these proteins could also be elicited after 30 minutes in the presence of 50 pmol/L DTT (Fig  8a) , a treatment condition not conducive to LFA-1 activation (Fig 1) . Thus, there were no apparent changes in NK cell MPB-reactive proteins that uniquely correlated with LFA-l activation by DTT. For personal use only. on September 14, 2017. by guest www.bloodjournal.org From KIM185 MoAbs, which bind two distinct epitopes in this region, stabilize or induce conformational changes in LFA-1 associated with an activated adhesive state.".3" If DTT reduced disulfides in the cysteine-rich domain, it seemed likely that one or both epitopes recognized by these MoAbs might have been altered. However, the reactivity of neither KIM127 nor KIM185 MoAbs with N K cell LFA-I was detectably affected by DTT treatment (Fig 9) . Both MoAbs were functionally active in NK cells. Within I O minutes at 37°C. they elicited an increase in LFA-l-dependent conjugate formation of otherwise untreated NK cells that corresponded to an approximately fivefold increase above basal levels for 10 pg/mL KIM185 and a twofold to threefold increase for 50 pg/mL KIM 127. Under conditions in which LFA-I was maximally activated by these MoAbs, neither DTT nor PMA was able to increase conjugate formation further (data not shown).
Immunoprecipitation analysis of LFA-I. To investigate the possibility that LFA-I might have been chemically modified by DTT at some locus other than the binding sites of KIM127 and KIM185 MoAbs, LFA-I was immunoprecipitated from DTT-treated cells. The HSB2 T-cell line was used for these experiments because immunofluorescence analysis showed them to express LFA-I at levels comparable with those of NK cells (data not shown). They showed adhesion to U i l I E 3 target cells that was ( l ) strictly dependent on target cell ICAM-I expression, as indicated by minimal conjugate formation with control B73Hl target cells (Fig loa) , (2) (Fig lob, lane  G) . There was no discernable effect of DTT treatment on migration or apparent recovery of either LFA-I chain (Fig  lob, lanes G and H) . When membrane proteins were labeled with MPB to detect free thiols, analysis of whole cell lysates showed three heavily biotinylated proteins that migrated at apparent molecular weights of 65, 70, and 1 17 kD in both untreated and DTT-treated cells (Fig lob, lanes A and B,  respectively ). There were no detectable MPB-labeled proteins comigrating with LFA-I chains either in the whole cell lysates (Fig lob, lanes A and B) or in LFA-I immunoprecipitates from untreated and DTT-treated cells (Fig lob, lanes D  and E, respectively) . Trace amounts of MPB-labeled proteins comigrating with the 65-and 70-kD bands were precipitated by control IgGl (Fig lob, lane C) as well as KIM 185 MoAb (Fig lob, lanes D and E) and, thus, were considered nonspecific carry-over proteins. For personal use only. on September 14, 2017. by guest www.bloodjournal.org From vital immunologic functions such as trafficking of leukocytes into and out of the peripheral circulation, migration of leukocytes in the tissues, and a variety of immunologically important cell-cell interactions of which NK cytolysis of tumors and virus-infected cells is one example. LFA-l and other members of the integrin family of adhesion receptors normally reside on cell membranes in a default low-avidity ligand-binding state but may be converted via conformational changes to a high-avidity ligand-binding state in response to intracellular signals, a process that has been referred to as "inside-out'' signal transduction.' The ability of LFA-1 to reversibly convert between low-and high-avidity states is likely to be central to its participation in the various immunologic functions outlined above. Therefore, a detailed understanding of the signaling pathway(s) involved in "inside-out" signal transduction will be crucial to the understanding of how LFA-l-dependent immunologic functions are normally regulated in the healthy organism and how they might be therapeutically manipulated in patients to control disease. Although the involvement of LFA-l in a variety of NK cell functions has been well documented, very little is known about mechanisms by which NK cells regulate LFA-l adhesive function. Therefore, the present studies were undertaken to begin characterization of intracellular signaling pathways by which LFA-l avidity is regulated in NK cells.
A focus of the present investigation was on DTT, a dithiol compound reported to modulate adhesive function of several different integrins, including aMP2 of neutrophils, a5pl of effects of both PMA and DTT, it had no effects on basal levels of conjugate formation, an energy-dependent function (Fig 4) ; (2) calphostin C only partially inhibited the adhesion-stimulatory effects of CD16 cross-linking (Fig 6) ; and (3) the fluorescent dyes used to identify NK cells in conjugate assays rapidly leak (within seconds) from cells on loss of plasma membrane integrity to such an extent that nonviable NK cells were intrinsically excluded from conjugate analysis in all experiments. Staurosporine, a less selective inhibitor of PKC that acts by a mechanism distinct from that of calphostin C, also abrogated DTT activation of LFA-I without affecting basal LFA-l-dependent adhesion or cell viability; however, we found that what is considered to be a relatively high concentration of staurosporine (5 pmol/L) was required to achieve maximal inhibition (data not shown). Similar concentrations of staurosporine were used in previous investigations to inhibit activation of LFA-I in T cells by PMA or antigen-receptor cross-linking' and, paradoxically, to promote an increase in LFA-l-dependent adhesion in B cells.34 Calphostin C inhibits PKC activation by preventing binding of phorbol esters and diacylglycerol to a cysteine-rich motif in the Cl regulatory domain of PKC that has also been recently identified in other signal-transducing enzymes less sensitive to ~taurosporine.~".~' This raises the possibility that PMA and/or DTT may activate LFA-I by binding a calphostin C-sensitive regulatory site on an enzyme other than PKC. Alternatively, these findings may reflect the promiscuous inhibition of multiple kinases by staurosporine. 4' DTT and PMA pathways of LFA-I activation differed with respect to sensitivity to calyculin A, a selective inhibitor of serinehhreonine protein phosphatases PP-l and PP-2A. Calyculin A not only abrogated the stimulatory effects of PMA on NK-target cell adhesion, but also inhibited the low basal levels of LFA-l-dependent conjugate formation that occurred in the absence of PMA. By contrast, calyculin A, at concentrations IO-fold (Fig 4) to 100-fold (not shown) greater than the minimum required for complete inhibition of basal and PMA-stimulated conjugate formation (50 nmoll L), only partially inhibited LFA-I activation by DTT. This relationship was confirmed by the comparable results obtained with okadaic acid, which inhibits serinekhreonine protein phosphatase activity via a mechanism distinct from that of calyculin A." It seemed unlikely that these results could have reflected DTT inactivation of the phosphatase inhibitors because ( l ) the two inhibitors have substantially different structures, neither of which has free thiol groups, disulfides, or cation-binding features likely to have been targeted by DTT,J' and (2) this would have been incompatible with the dose-response plateau in calyculin A inhibition of DTT stimulatory effects (Fig 4) . LFA-l activation that resulted from cross-linking of CD16, similar to that elicited by PMA treatment, was abrogated in the presence of calyculin A. Thus, relative insensitivity to calyculin A and okadaic acid was a feature of LFA-I activation unique to DTT. The site(s) of the serinehhreonine phosphatase activity essential for LFA activation through CD I6 and PMA as well as the mechanistic basis by which DTT partially circumvented this activity requirement are important issues that require further investigation.
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Structure&nction relationship. Structural features identified to be of critical importance in the adhesion-activating efficacy of DTT included the presence of at least two reduced SH groups within a single molecule and an apparently novel additional constraint that the pair of SH groups be appropriately spaced or oriented. This conclusion was predicated on the observed failure to activate LFA-l by (1) oxidized DTT; (2) monothiol compounds such as 2-mercaptoethanol (Fig  3) , cysteine, and glutathione (data not shown); and (3) the dithiol compound DMP, in which two SH groups are present on adjacent carbon atoms (Fig 3) . Other features of DTT structure such as the presence and orientation of hydroxyl groups on carbons 2 and 3 appeared to be irrelevant to LFA-1 activation.
Two important known functional attributes of DTT are chelation of divalent cations33 and efficient reduction of disulfides to free thiols.@ However, the collective experimental findings of this investigation failed to clearly support either of these attributes as a likely basis of the LFA-activating effects of DTT. Arguing against the likely importance of cation chelating properties was (1) the difference between DTT and the Ca2+ chelating agent EGTA with respect to requirements for sustained LFA-1 activation (the activated state rapidly subsided on removal of EGTA but not of DTT), (2) the ability of DTT to elevate conjugate formation significantly above the maximal EGTA-inducible level, and (3) the failure of DMP, which exhibits Zn2+chelating properties comparable or superior to to activate LFA-l-dependent adhesion. The potential role of DTT-mediated disulfide reduction was called into question by several additional observations. First, although an LFA-l-activating concentration of D I T (500 ymom) clearly elicited significant changes in NK cell-associated proteins consistent with disulfide reduction, virtually all the major detected changes could be reproduced either by brief (10-minute) treatment with DMP or by more prolonged (30-minute) treatment with 50 ymoV L D l T (Fig 8) , neither of which protocols resulted in LFA-1 activation (Figs 1 and 3) . Second, DTT occasionally reduced proteins that were apparently less susceptible to reduction by DMP; however, this was detected only intermittently, whereas the stimulatory effect of DTT on LFA-1 adhesion was very consistent. Also seemingly inconsistent with a role of Dm-mediated disulfide reduction was the failure of albumin, when present at the time of DTT treatment, to influence LFA-1 activation with respect to kinetics, DTT concentration-dependency, or response maxima (Fig 1) . Albumins are rich in disulfide groups (17 to 18 per molecule, the estimated concentration of cystine disulfide residues in these experiments was -250 mom), most of which are highly susceptible to reduction by D m 5 and, thus, would be expected to compete to some extent with NK cell-associated disulfides for reduction by DTT. The possibility that DTT might have activated adhesion by direct chemical modification of LFA-1 was indicated to be unlikely by the failure to detect reduced thiol groups in LFA-1 a L and 0 2 chains immunoprecipitated from DTT-treated cells (Fig 10) and by the apparent insensitivity to DTT treatment of epitopes within the cysteine-rich domain of the P2 subunit recognized by KIM127 and KIM185 MoAbs (Fig 9) .
Our data do not rule out the possibility that 500 kmol/L DTT may have exclusively reduced a disulfide substrate which was not detected because of low abundance on the membrane or for a variety of other reasons. However, the above arguments suggest that an alternative model might also be considered in which the structural geometry of Dl", particularly with respect to SH group spatial positioning, may promote LFA-1 activation for reasons other than conferring an ability to chelate cations or reduce disulfides. For example, the effect of DTT might be related to its binding kinetics in a signaling complex, perhaps analogous to the cysteine-dependent physical association of certain signaling complexes involved in T-cell activation!6 Alternatively, DTT might bind and induce modification of thiol-associated cellular structural elements important in LFA-1 avidity regulation (see below). DTT is membrane ~e n n e a n t ?~ a feature consistent with the possibility of an intracellular site of action. If this model is valid, it raises the possibility of generating structurally related compounds by which the activation state of LFA-1 and possibly of other integrins might be manipulated without undesirable chelating and protein-reducing activities of DTT.
Locus of integrin activation by D l T . This investigation was undertaken with the idea that DTT might be a general stimulus for integrin activation, a notion supported by our finding that NK cell LFA-1, similar to several other previously investigated integrin~,'~"~ was activated in the presence of DTT. The ability of DTT to activate multiple integrins suggested the existence of a common site of integrin avidity regulation that was targeted by DTT. However, the likely identity of such a site was not immediately evident, and its elucidation may be subject to certain caveats. For example, NK cells express the aMP2 integrin adhesion molecule, which also binds ICAM-l under certain conditions.' However, because MoAbs directed against the LFA-1 a L chain completely blocked NK cell adhesion to the U i l l E 3 target cells (Fig 2) , the aMP2 adhesion molecule was apparently minimally involved, if at all, in the observed NK-target cell adhesive interactions. The lack of aMP2 participation in DTT-stimulated NK cell adhesion, which contrasted results previously observed in ne~trophils,'~ may have reflected the relatively low density of aMP2 integrin expression on membranes of resting NK cells!8 The alternative possibility that DTT activated aMP2 adhesion to a ligand other than ICAM-l was more likely. This was certainly the case in DTT stimulation of neutrophil adhesion to serum-or albumin-coated plastic surface~.'~ An endothelial cell ligand bound by neutrophil aMP2 was not identified." Comparison of DTT effects on LFA-1 and a 5 P l adhesion showed other discrepancies that were more difficult to reconcile with a common locus of DTT action. Our results with calphostin C suggested PKC enzymatic activity as an essential basis of DTT activation of LFA-1. Activation of HL-60 a501 by DTT was reported to be relatively insensitive to the PKC inhibitor staurosporine,'8 a result that was used to argue against involvement of PKC in that system. As discussed above, we have also observed a requirement for a relatively high staurosporine concentration to inhibit LFA-1 activation by DTT, but the promiscuous effects of For personal use only. on September 14, 2017. by guest www.bloodjournal.org From this inhibitor on multiple kinases and its paradoxical effects on LFA-I avidity in different studies complicate interpretation of this result. There was evidence that DTT acted directly on purified a5Pl molecules to alter their adhesive function, although the mechanism did not appear to involve disulfide reduction." However, DTT effects on purified a5P1 integrin did not fully account for effects observed with the cell-associated form of the integrin; the a5pl adhesion response in intact cells was sustained when cells were washed free of DTT, whereas fibronectin binding by purified a 5 p l molecules was rapidly reversible under these conditions.'8 On the other hand, actin polymerization inhibitors blunted DTT activation of both NK cell LFA-1 adhesion to ICAM-1 (Fig 5) and HL-60 a5Pl adhesion to fibronectin," results that implicated the actin-dependent cytoskeleton or membrane skeleton as a common requirement for DTT modulatory effects on both integrins. Therefore, these actin-based structures or elements intimately associated with them would appear to be the most likely candidates for a putative common integrin regulatory site targeted by DTT.
